SET protein accumulates in HNSCC and contributes to cell survival: Antioxidant defense, Akt phosphorylation and AVOs acidification-Reference-Cited by-同舟云学术

SET protein accumulates in HNSCC and contributes to cell survival: Antioxidant defense, Akt phosphorylation and AVOs acidification

Published:2012-11 Issue:11 Volume:48 Page:1106-1113
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Leopoldino Andréia M.,Squarize Cristiane H.,Garcia Cristiana B.,Almeida Luciana O.,Pestana Cezar R.,Sobral Lays M.,Uyemura Sérgio A.,Tajara Eloiza H.,Silvio Gutkind J.,Curti Carlos

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference59 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients;Akervall;Clin Cancer Res,2004

3. Recurrence interval affects survival after local relapse of oral cancer;Mucke;Oral Oncol,2009

4. Dysregulated molecular networks in head and neck carcinogenesis;Molinolo;Oral Oncol,2009

5. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative;Molinolo;Clin Cancer Res,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merkel Cell Polyomavirus targets SET/PP2A complex to promote cellular proliferation and migration;Virology;2024-09

2. Spermidine Suppresses Oral Carcinogenesis through Autophagy Induction, DNA Damage Repair, and Oxidative Stress Reduction;The American Journal of Pathology;2023-12

3. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer;Cellular Oncology;2023-11-16

4. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma;Journal of Oral Pathology & Medicine;2023-11-09

5. TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer;2023-09-04